COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,209 Articles (22,213 medRxiv, 7,996 bioRxiv)

Most recent first Previous |  Page 2646: Articles 26451-26460  | Next

Modeling the Effects of Non-PharmaceuticalInterventions on COVID-19 Spread in Kenya
Gathungu, D. K., Ojiambo, V. N., Kimathi, M. E. M., Mwalili, S. M.
10.1101/2020.05.14.20102087 — Posted: 2020-05-20
Systematic and Statistical Review of COVID19 Treatment Trials
Siordia, J. A., Bernaba, M., Yoshino, K., Ulhaque, A., Kumar, S., Bernaba, M., Bergin, E.
10.1101/2020.05.16.20102095 — Posted: 2020-05-20
Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study
Tan, Q., Jin, Y.
10.1101/2020.05.15.20102392 — Posted: 2020-05-20
COVID-19; Systematic and literature review of transmission, case definitions, clinical management and clinical trials.
McArthur, L., Sakthivel, D., Ataide, R., Chan, F., Richards, J. S., Narh, C. A.
10.1101/2020.05.14.20102475 — Posted: 2020-05-20
Who is lonely in lockdown? Cross-cohort analyses of predictors of loneliness before and during the COVID-19 pandemic
Bu, F., Steptoe, A., Fancourt, D.
10.1101/2020.05.14.20101360 — Posted: 2020-05-20
Risk interactions of coronavirus infection across age groups after the peak of COVID-19 epidemic
Yu, X.
10.1101/2020.05.17.20105049 — Posted: 2020-05-19
Clinical evaluation of IFN beta1b in COVID-19 pneumonia: a retrospective study
Estebanez, M., Martinez-Oliveira, G., Mata, T., Marti, D., Gutierrez, C., De Dios, B., Dolores Herrero, M., Roel, A., Martinez, Y., Aguirre, A., Alcantara Nicolas, F., Fernandez Gonzalez, P., Lopez, E., Ballester, L. E., Mateo-Maestre, M., Campos, S., Sanchez-Carrillo, M. J., Fe, A., Membrillo de Novales, F. J.
10.1101/2020.05.15.20084293 — Posted: 2020-05-19
Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2
Mick, E., Kamm, J., Pisco, A. O., Ratnasiri, K., Babik, J. M., Calfee, C. S., Castaneda, G., DeRisi, J. L., Detweiler, A., Hao, S., Kangerlaris, K. N., Kumar, G. R., Li, L. M., Mann, S. A., Neff, N., Prasad, P. A., Serpa, P. H., Shah, S. J., Spottiswoode, N., Tan, M., Christenson, S. A., Kistler, A., Langelier, C.
10.1101/2020.05.18.20105171 — Posted: 2020-05-19 Discussion: Onsite | Offsite
Empirical Assessment of COVID-19 Crisis Standards of Care Guidelines
Jezmir, J. L., Bharadwaj, M., Kishore, S. P., Winkler, M., Diephuis, B., Kim, E. Y., Feldman, W. B.
10.1101/2020.05.16.20098657 — Posted: 2020-05-19
Reciprocal association between participation to a national election and the epidemic spread of COVID-19 in France: nationwide observational and dynamic modeling study.
Zeitoun, J.-D., Faron, M., Manternach, s., Fourquet, J., Lavielle, M., lefevre, j.
10.1101/2020.05.14.20090100 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).